A case of suspected autoimmune encephalitis after the introduction of atezolizumab + bevacizumab therapy for hepatocellular carcinoma

This is the case of a 68-year-old male. On the 14th day after the introduction of atezolizumab, an immune-checkpoint inhibitor (ICI) for hepatocellular carcinoma, the patient developed difficulty in moving and had chills. Since body temperature was 39.4°C, consciousness disorder developed on the 16t...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Kanzo 2021/09/01, Vol.62(9), pp.590-592
Hauptverfasser:	Hirata, Taiki, Sugimoto, Katsutoshi, Kakegawa, Tatsuya, Takahashi, Hiroshi, Tomita, Yusuke, Wada, Takuya, Abe, Masakazu, Yoshimasu, Yu, Takeuchi, Hirohito, Saito, Kazuhiro, Terashi, Hiroo, Itoi, Takao
Format:	Artikel
Sprache:	eng ; jpn
Schlagworte:	atezolizumab encephalitis immune-related adverse events
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!